PRESS RELEASE Planned Inclusion of Therapeutic Drug Monitoring (TDM) Laboratory Tests in the General Healthcare System (GeSY) Following repeated requests submitted over the past several years by the Cyprus Crohn's and Colitis Association (CYCCA) and the Cyprus Gastroenterology Society (CGS), the Health Insurance Organisation (HIO) has announced the planned inclusion of Therapeutic Drug Monitoring (TDM) laboratory tests in the General Healthcare System (GeSY) for the biological therapies adalimumab and infliximab. These tests include Drug Level and Anti-Drug Antibody testing. The Health Insurance Organisation (HIO) has scheduled the inclusion of these laboratory tests in GeSY during 2027....